Get App Open
In App
Credit Cards
Open App
Loans

ICICI Prudential Nifty Pharma Index Fund - Direct Plan - IDCW

  • Regular
  • Direct
Category : Sectoral/Thematic
  • NAV
    : ₹ 17.1427 -0.36%
    (as on 07th November, 2025)
Crisil Rating

Not Rated

Rank not available for the fund
Risk-O-Meter
Very High Risk

The fund has 99.98% investment in domestic equities of which 53.23% is in Large Cap stocks, 19.75% is in Mid Cap stocks, 2.61% in Small Cap stocks.

Suitable For : Investors who have advanced knowledge of macro trends and prefer to take selective bets for higher returns compared to other Equity funds. At the same time, these investors should also be ready for possibility of moderate to high losses in their investments even though overall market is performing better.

This Scheme
VS
  • Benchmark
    Nifty Pharma TRI
  • NA
  • NA
  • Gold
Compare with
  • Date : -
  • NAV : -
  • Date : -
  • Investment : -
  • Value on selected date : -
  • Returns Calculator
  • SIP Calculator
  • VIP (Value Avg)
Amount
  • Investment Date
  • Sell Date
  • Investment Value
    -
  • Sell Value
    -
  • Profit/Loss
    -
  • Annualised Returns
    -
  • Date : -
  • Investment : -
  • Value on selected date : -

Returns (NAV as on 07th November, 2025)

Period Invested for ₹10000 Invested on Latest Value Absolute Returns Annualised Returns Category Avg Rank within Category
1 Week 31-Oct-25 9996.90 -0.03% - -0.79% 44/231
1 Month 07-Oct-25 10131.50 1.31% - 0.87% 85/227
3 Month 07-Aug-25 10213.30 2.13% - 3.98% 176/224
6 Month 07-May-25 10353.40 3.53% - 9.35% 203/213
YTD 01-Jan-25 9489.60 -5.10% - 4.42% 185/201
1 Year 07-Nov-24 9875.90 -1.24% -1.24% 3.56% 143/187
2 Year 07-Nov-23 14526.70 45.27% 20.50% 20.54% 69/141
Since Inception 14-Dec-22 17142.70 71.43% 20.41% 13.90% 41/199

SIP Returns (NAV as on 07th November, 2025)

Period Invested for ₹1000 SIP Started on Investments Latest Value Absolute Returns Annualised Returns
1 Year 07-Nov-24 12000 12244.68 2.04 % 3.78 %
2 Year 07-Nov-23 24000 26215 9.23 % 8.71 %
 

Tax Treatment

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.

Portfolio (Updated on 31st Oct,2025)

Equity Holding : 99.98% | F&O Holdings : 0.00%| Foreign Equity Holdings : 0.00%| Total : 99.98%
No of Stocks : 20 (Category Avg - 44.06) | Large Cap Investments : 53.23%| Mid Cap Investments : 19.75% | Small Cap Investments : 2.61% | Other : 24.41%

Top 10 Stocks in Portfolio

How to read this table?
Stock Invested in Sector Value(Mn) % of Total Holdings 1M Change 1Y Highest Holding 1Y Lowest Holding Quantity 1M Change in Qty
# Sun Pharmaceutical Industries Ltd. Pharmaceuticals 201.4 22.18% 0.00% 25.51% (Apr 2025) 21.61% (Sep 2025) 1.19 L -0.25 k
# Divis Laboratories Ltd. Pharmaceuticals 96.8 10.66% 0.00% 11.01% (May 2025) 9.3% (Sep 2025) 14.36 k -27.00
# Cipla Ltd. Pharmaceuticals 95.5 10.51% 0.00% 11.42% (Aug 2025) 10.2% (Dec 2024) 63.59 k -0.13 k
# Dr. Reddys Laboratories Ltd. Pharmaceuticals 82.5 9.08% 0.00% 10.28% (Dec 2024) 9.23% (Mar 2025) 68.88 k -0.14 k
# Lupin Ltd. Pharmaceuticals 53.7 5.91% 0.00% 6.89% (Dec 2024) 5.7% (Jul 2025) 27.35 k -56.00
# Torrent Pharmaceuticals Ltd. Pharmaceuticals 42.1 4.64% 0.00% 4.85% (Sep 2025) 3.73% (Oct 2024) 11.83 k -21.00
# Laurus Labs Ltd. Pharmaceuticals 41.9 4.61% 0.00% 4.29% (Aug 2025) 2.44% (Oct 2024) 43.92 k -89.00
# Aurobindo Pharma Ltd. Pharmaceuticals 36 3.97% 0.00% 4.92% (Oct 2024) 3.67% (Aug 2025) 31.62 k -63.00
# Alkem Laboratories Ltd. Pharmaceuticals 35.1 3.86% 0.00% 3.93% (Sep 2025) 3.31% (Jul 2025) 6.37 k -9.00
# Glenmark Pharmaceuticals Ltd. Pharmaceuticals 32.2 3.55% 0.00% 3.93% (Jul 2025) 2.69% (Apr 2025) 17.03 k -33.00
- indicates change in weight in the portfolio. # indicates a new entry.
Name Type of Instrument Weight (%)
TREPS TREPS 0.67%
Net Receivables Net Receivables -0.65%

Risk Ratios

Ratios calculated on daily returns for last 3 years (Updated as on 31st October, 2025)

  • Standard Deviation

    High volatility
    14.42vs13.95
    Category Avg
  • Beta

    High volatility
    1vs0.86
    Category Avg
  • Sharpe Ratio

    Better risk adjusted returns
    0.93vs0.91
    Category Avg
  • Treynor's Ratio

    Poor risk adjusted returns
    0.13vs0.17
    Category Avg
  • Jensen's Alpha

    Poor risk adjusted returns
    0.05vs3.58
    Category Avg

Alternative Funds (Category Peers)

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
Nippon India Taiwan Equity Fund - Direct Plan - Growth NA 421.51 1.56 18.80 61.31 42.13 41.29
Aditya Birla Sun Life International Equity Fund - Direct Plan - Growth NA 273.51 -1.72 3.82 18.65 26.30 17.89
Franklin Asian Equity Fund - Direct - Growth NA 279.13 1.42 10.85 23.53 20.70 16.64
Nippon India Japan Equity Fund - Direct Plan - Growth NA 292.35 -0.83 5.78 14.81 20.52 19.78
Quant BFSI Fund - Direct Plan - Growth NA 655.17 4.96 7.90 22.48 20.19 0.00
HDFC Transportation and Logistics Fund - Direct Plan - Growth NA 1651.55 -0.37 11.10 25.24 20.11 0.00
DSP Banking & Financial Services Fund - Direct Plan - Growth NA 1419.62 3.62 7.62 10.70 18.25 0.00
ITI Banking and Financial Services Fund - Direct Plan - Growth NA 333.18 4.60 7.67 9.73 17.83 15.60
SBI Banking & Financial Services Fund - Direct Plan - Growth NA 9273.44 2.90 6.11 11.70 16.53 20.38
Mirae Asset Banking and Financial Services Fund - Direct Plan - Growth NA 2014.27 3.68 5.76 10.24 14.98 18.89

More Funds from ICICI Prudential Mutual Fund

Out of 108 mutual fund schemes offered by this AMC, 6 is/are ranked 5 * , 8 is/are ranked 4 * , 9 is/are ranked 3 * , 5 is/are ranked 2 * , 3 is/are ranked 1 * , and 77 schemes are not ranked. See more about AMC

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
ICICI Prudential Large Cap Fund - Direct Plan - Growth 5 73034.52 1.08 3.47 5.99 7.15 18.03
ICICI Prudential Multi-Asset Fund - Direct Plan - Growth 4 67999.63 1.06 6.01 8.32 13.33 19.96
ICICI Prudential Balanced Advantage Fund - Direct Plan - Growth NA 66750.51 0.97 3.69 6.34 9.93 13.78
ICICI Prudential Value Fund - Direct Plan - Growth 5 55444.54 1.76 4.43 7.25 7.57 21.31
ICICI Prudential Equity & Debt Fund - Direct Plan - Growth 5 46392.05 0.79 4.46 6.63 9.50 19.32
ICICI Prudential Liquid Fund - Direct Fund - Growth 2 45629.29 0.47 1.45 3.02 6.74 7.07
ICICI Prudential Money Market Fund - Direct Plan - Growth 4 34019.73 0.48 1.47 3.37 7.71 7.66
ICICI Prudential Corporate Bond Fund - Direct Plan - Growth 3 33753.23 0.58 1.62 3.45 8.51 8.17
ICICI Prudential Equity - Arbitrage Fund - Direct Plan - Growth 3 32573.00 0.60 1.54 3.14 7.04 7.71
ICICI Prudential India Opportunities Fund - Direct Plan - Growth NA 30802.31 2.36 5.69 8.11 9.01 23.25

Forum

+ See More

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
Close Outskill Genai